Skip to main content

Want a detailed portfolio tracker?

Regenxbio (RGNX) P/E (2015 - 2026)

Regenxbio (RGNX) P/E from Sep 30, 2015 to Jul 21, 2026. The TTM Regenxbio (RGNX) P/E is -1.82. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Regenxbio (RGNX)

YearP/EChange
2026-1.82-51.72%
2025-3.76+123.94%
2024-1.68-44.07%
2023-3.00-123.27%
202212.91+17.03%
202111.03-172.49%
2020-15.22-4.39%
2019-15.92-220.56%
201813.20-203.34%
2017-12.78+26.52%
2016-10.10-71.07%
2015-34.91N/A

Comparison Regenxbio (RGNX) P/E with competitors

Regenxbio (RGNX) P/E is -1.82.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.09%
NBYStablecoin Development Corp0.00-100.24%
ENLVEnlivex Ltd0.07-104.12%
FGENFibroGen Inc0.24-113.22%
CHRSCoherus Biosciences Inc0.85-146.73%
FBIOFortress Biotech Inc0.95-152.26%
ORMPOramed Pharmaceuticals Inc1.50-182.77%
AGENAgenus Inc3.01-265.73%
INVAInnoviva Inc3.15-273.68%
VXRTVaxart Inc3.55-295.47%
CRMDCorMedix Inc3.63-299.81%
CVACCureVac N.V.4.45-344.81%
GLPGGalapagos NV4.86-367.56%
SRPTSarepta Therapeutics Inc4.88-368.84%
ABEOAbeona Therapeutics Inc5.39-396.67%
ABUSArbutus Biopharma Corp5.60-408.13%
ZVRAZevra Therapeutics Inc5.89-424.19%
SPROSpero Therapeutics Inc6.23-442.98%
CGENCompugen Ltd6.31-447.69%
RIGLRigel Pharmaceuticals6.87-478.42%
SLXNSilexion Therapeutics Corp7.30-501.77%
OMEROmeros Corporation9.26-609.85%
AUPHAurinia Pharmaceuticals Inc9.58-627.82%
PLXProtalix BioTherapeutics Inc10.89-699.74%
ACADAcadia Pharmaceuticals Inc11.73-745.86%
TBPHTheravance Biopharma Inc12.26-775.24%
ADMAAdma Biologics Inc12.42-783.83%
HRMYHarmony Biosciences Holdings Inc13.82-861.04%
SABSSAB Biotherapeutics Inc14.14-878.44%
NAGENiagen Bioscience Inc14.82-915.99%
INCYIncyte Corp15.82-971.30%
REGNRegeneron Pharmaceuticals Inc15.86-973.18%
PBYIPuma Biotechnology Inc17.32-1053.53%
CPRXCatalyst Pharmaceuticals Inc17.44-1060.33%
EXELExelixis Inc17.54-1065.77%
TGTXTG Therapeutics Inc18.97-1144.41%
MDXGMimedx Group Inc20.55-1231.77%
XOMAXOMA Royalty Corp22.87-1359.68%
ARGXArgen X SE24.30-1438.06%
CTMXCytomX Therapeutics Inc24.82-1466.87%
XOMAOXOMA Royalty Corp25.34-1495.71%
HALOHalozyme Therapeutics Inc25.62-1511.06%
XOMAPXOMA Royalty Corp25.67-1513.62%
VRTXVertex Pharmaceuticals Inc27.99-1641.63%
RPRXRoyalty Pharma plc - Class A28.69-1679.79%
SLNOSoleno Therapeutics Inc29.02-1697.84%
ASNDAscendis Pharma A/S30.09-1756.77%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2187.77%
APLSApellis Pharmaceuticals Inc39.02-2248.85%
BMRNBiomarin Pharmaceutical Inc42.21-2424.55%
KRYSKrystal Biotech Inc45.34-2597.01%
ONCBeiGene Ltd69.54-3929.50%
PHARPharming Group N.V.75.03-4231.56%
TECHBio-Techne Corp101.96-5714.72%
VCELVericel Corp109.92-6153.23%
ALNYAlnylam Pharmaceuticals Inc117.96-6596.19%
GMABGenmab140.29-7825.63%
TLXTelix Pharmaceuticals Ltd162.15-9029.55%
CORTCorcept Therapeutics Inc212.86-11821.79%